Milky Way Biotech is developing a single-pill gene therapy utilizing Adeno-Associated Viruses (AAVs) to provide a long-term solution for lactose intolerance by delivering genetic information to intestinal cells. This therapy aims to eliminate the dietary restrictions and discomfort associated with lactose intolerance, allowing individuals to enjoy a diverse diet without adverse effects.
Funding
$20K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Lactose intolerance causes digestive discomfort and limits dietary choices, impacting the quality of life for many individuals. Current management strategies involve avoiding dairy products or using temporary solutions like lactase supplements, which require constant vigilance and may not fully alleviate symptoms.
Solution
Milky Way Biotech is developing a single-administration gene therapy designed to provide a long-term solution for lactose intolerance. The therapy uses adeno-associated virus (AAV) vectors to deliver genetic instructions to cells in the small intestine, enabling them to produce lactase, the enzyme needed to digest lactose. This approach aims to eliminate the need for dietary restrictions and reduce the discomfort associated with lactose intolerance, allowing individuals to consume dairy products without adverse effects. The non-integrating nature of the AAV vector ensures that the patient's native genome remains unaltered.
Target Audience
The primary target audience includes individuals diagnosed with lactose intolerance who are seeking a long-term solution to manage their condition and improve their dietary freedom.
Features
- Single-administration gene therapy using AAV vectors for targeted delivery to intestinal cells
- Non-integrating vector design to avoid alterations to the patient's existing genome
- Aims to provide long-term lactase production, reducing or eliminating lactose intolerance symptoms
- Designed to allow individuals to consume dairy products without dietary restrictions or discomfort
- Rigorous testing and clinical trials to ensure safety and efficacy, adhering to international safety standards